A new study finds that brain shrinkage in Alzheimer’s disease varies greatly among individuals, with distinct patterns rather than a uniform progression. These findings may pave the way for ...
1d
Actively Exploring Partnership for Alzheimer's DevelopmentSupplementary Financing Concluded in Q4 ROCHESTER, N.Y., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage bio ...
Researchers have created a highly detailed cellular map of Alzheimer’s disease progression, revealing new insights into the ...
Verywell Health on MSN3d
What’s the Difference Between Dementia and Alzheimer’s?Medically reviewed by Brigid Dwyer, MD Dementia includes conditions that cause memory loss, confusion, personality changes, ...
An analysis of brains at various stages of Alzheimer's found that neurons called inhibitory neurons are the first to be affected by the disease.
The use and ethics of antipsychotic drugs in nursing homes is an ongoing discussion. Learn why these medications are ...
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: ...
BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announces that EMA's Committee for Medicinal Products for Human Use (CHMP) has issued a positive recommendation regarding BioArctic's partner Eisai ...
INmune Bio, Inc. (NASDAQ: INMB) (the "Company"), a clinical-stage inflammation and immunology company focused on developing treatments that harness ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback